TC BioPharm (TCBP) said Friday that the Nasdaq Hearings Panel determined to delist the company's shares from the exchange for failing to comply with the minimum bid price requirement.
The company said its shares will be suspended from trading on the Nasdaq at market open March 24.
TC BioPharm said it expects its American depositary shares to be eligible to trade on the OTC Markets Monday.
Shares of the company were down over 60% in recent trading.
Price: 0.55, Change: -0.99, Percent Change: -64.09
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。